Federal contractor · COSTA MESA, CA

INTEGRATED BEHAVIORAL HEALTH, INC.

INTEGRATED BEHAVIORAL HEALTH, INC. received $575.4K in federal contract obligations in FY2026, on 4 awards (+45% vs FY2025). Since FY2019: $8.9M. Its largest customer was Food and Drug Administration ($575.4K).

Obligations · FY2026
$575.4K
New awards
4
Sole-source
0.0%
Single offer
100%
UEI
L9YZF5SG6WN1
Other than small business
Open in the contracts explorerRelationship graph

Spending by fiscal year

Obligations per federal fiscal year (October–September).

  1. 1.5MFY2019
  2. 1MFY2020
  3. 1.2MFY2021
  4. 1.7MFY2022
  5. 1.2MFY2023
  6. 1.4MFY2024
  7. 396KFY2025
  8. 575.4KFY2026

Top buying agencies

Obligations in FY2026.

  1. Food and Drug Administration$575.4K100%
    4 awards

What was bought · Where the work was performed

Obligations in FY2026.

What was bought

  1. Professional services$575.4K100%

Where the work was performed

  1. Montgomery County, MD$575.4K100%

Integrity signals

Shares of the year's obligations, next to the country's.

  • Low competition100%
    US 39% · $575.4K
  • Sole-source awards0.0%
    US 30% · $0
  • Single-offer competitions100%
    US 8.7% · $575.4K
  • Urgency justifications0.0%
    US 5.1% · $0

A signal is a reason to look closer, not evidence of wrongdoing: most sole-source awards are lawful and justified.

Largest awards

  1. UNDERSTANDING THE PREVALENCE, EXPERIENCES, KNOWLEDGE, AND PERCEPTIONS OF FALSIFIED AND UNAPPROVED PHARMACEUTICALS IN AN ENRICHED POPULATION BEING ASSESSED FOR OR ENTERING SUBSTANCE USE DISORDER TREATMENT$1M
    Food and Drug Administration· Montgomery County, MD· Professional services· Sep 16, 2022 – Mar 24, 2026· 75F40122F19002
  2. DATA RESOURCE FOR POST-MARKETING SURVEILLANCE OF NONMEDICAL USE (NMU) OF PHARMACEUTICALS AND USE OF ILLICIT DRUG SUBSTANCES ? SIX MONTH SURVEILLANCE REPORTS$1M
    Food and Drug Administration· Orange County, CA· Professional services· Sep 24, 2021 – Jul 6, 2026· 75F40121F19001
  3. EO 14398 - POST-MARKETING RX DRUG ABUSE SURVEILLANCE DATA$309.1K
    Food and Drug Administration· Montgomery County, MD· Professional services· Aug 17, 2026 – Aug 17, 2026· 75F40126F19003
  4. REDEFINING NONMEDICAL USE OF BUPRENORPHINE AND METHADONE IN THE ADDICTION SEVERITY INDEX-MULTIMEDIA VERSION (ASI-MV) CLINICAL ASSESSMENT TOOL$46.3K
    Food and Drug Administration· Montgomery County, MD· Professional services· Aug 18, 2026 – Aug 18, 2026· 75F40126F19004

Subawards

Matched by Unique Entity ID: the first-tier subawards this organization reported as a prime recipient, and those primes reported paying it.

As a prime: who it pays · FY2026

No subawards reported as a prime in FY2026.

As a sub-recipient: who pays it · FY2026

  • Sub-contracts: $40.2M (1 subaward)

1 prime

  1. LEIDOS, INC.$40.2M100%
    RESTON, VA · 1 subaward

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from FY2021.

Teaming partners

Companies this company reported paying, primes that reported paying it, from FFATA subaward reports.

Companies it pays

No subawards reported to other companies.

Primes that pay it

1 company · $40.2M reported

  1. LEIDOS, INC.$40.2M
    RESTON, VA · 1 subaward · Individual and family services

Primes report first-tier subawards of $30,000 or more themselves, and many go unreported (GAO-24-106214). Reporting moved from FSRS to SAM.gov in March 2025 and fewer sub-contracts have been reported since. Amounts are what primes reported; they are never added to prime award totals.

Source: Subawards (first-tier sub-contracts and sub-grants reported under FFATA) (U.S. Department of the Treasury, USAspending.gov (reports filed in SAM.gov, formerly FSRS)), data current to Oct 10, 2026, loaded Oct 10, 2026 · Subawards loaded from 2021.

Competitors

Companies that win from the same buyers in the same markets: obligations by agency and industry compared over the last three fiscal years.

Compared on 2 markets (agency × industry), FY2024–FY2026.

  1. HKS INC$1.3M
    DALLAS, TX · 54% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services
  2. NATIONAL INSTITUTE FOR PHARMACEUTICAL TECHNOLOGY & EDUCATION INC$1.5M
    MINNEAPOLIS, MN · 57% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services
  3. NORTH CAROLINA COMMUNITY HEALTH CENTER ASSOCIATION$1.7M
    RALEIGH, NC · 57% of this company's obligations are in markets they both serveFood and Drug Administration · Scientific research and development services

Showing the top 3 of 25 competitors. Open the profile for the full list.

Who sells to the same buyers in the same markets, not who wins against whom on a given contract. Prime contract obligations by the agency and NAICS code of each award; subawards are never added. A company is a family of legal entities, joined by parent UEI or, in part, by an AI reading of names.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2024–FY2026.

Source: Federal contract transactions (Federal Procurement Data System) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026.